Market Analysis and Insights:
The market for Next-Generation Sequencing Services is anticipated to grow at a CAGR of 19.91%, with an expected value of USD 20.4 billion in 2030.
The market for next-generation sequencing services is being catalyzed by various factors. A key contributor to this momentum is the escalating interest in personalized medicine and genomics research. Next-generation sequencing technology has brought about a fundamental shift in genomics research by facilitating precise and swift sequencing of substantial DNA and RNA volumes. This significant advancement has laid the groundwork for personalized healthcare endeavors, striving to tailor medical treatments based on an individual's genetic makeup. Furthermore, the decreasing costs associated with sequencing have democratized access to next-generation sequencing services, fostering ened utilization among academic institutions, research facilities, and pharmaceutical firms. Additionally, the evolution of technology, exemplified by the emergence of high-throughput sequencing platforms, has notably advanced market growth. These platforms empower researchers to concurrently analyze vast sample quantities, thereby bolstering the efficiency and output of sequencing services. Moreover, the escalating incidence of genetic disorders and the imperative for early disease identification have further bolstered market expansion. Collectively, these driving forces are projected to propel substantial growth in the Next-Generation Sequencing Services Market in the forthcoming years.
Next Generation Sequencing Services Market Scope :
| Metrics | Details |
| Base Year | 2023 |
| Historic Data | 2018-2022 |
| Forecast Period | 2024-2030 |
| Study Period | 2018-2030 |
| Forecast Unit | Value (USD) |
| Revenue forecast in 2030 | USD 20.4 billion |
| Growth Rate | CAGR of 19.91% during 2023-2030 |
| Segment Covered | By Type, By Technology ,By Application,By End User,By Region. |
| Regions Covered | North America, Europe, Asia Pacific, South America, Middle East and Africa |
| Key Players Profiled | Illumina, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., PerkinElmer, Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies, Inc., Eurofins Scientific SE, Pacific Biosciences of California, Inc., Oxford Nanopore Technologies Ltd., and Genotypic Technology Pvt Ltd. |
Market Definition
Advanced sequencing services involve cutting-edge technologies and methodologies employed for identifying the sequence of DNA or RNA molecules. These services are pivotal in expediting and streamlining the analysis of genetic information for a range of scientific and medical applications. They have significantly transformed genomics research and personalized medicine by facilitating swift and precise sequencing of extensive genetic data, surpassing traditional methods in terms of speed, affordability, and resolution.
NGS services are fundamental in a wide range of scientific investigations and medical practices by allowing the rapid and accurate sequencing of substantial DNA or RNA quantities. This advanced technology has transformed genomic studies, transcriptomics, metagenomics, and personalized healthcare, offering profound insights into disease mechanisms, the discovery of new biomarkers, and facilitating precision medical strategies. NGS services are critical in decoding the genetic complexities of diseases, driving progress in drug discovery, and enhancing our understanding of biological systems. They are increasingly utilized in diagnostics, pinpointing genetic variations, mutations, and gene expression profiles linked to diseases, thus enhancing patient care and treatment efficacy.
Key Market Segmentation:
Insights On Key Type
Targeted Sequencing Services is expected to dominate the Global Next-Generation Sequencing Services market. Targeted sequencing services involve capturing specific genomic regions of interest for analysis, allowing for a more cost-effective and focused approach compared to whole genome sequencing. As personalized medicine and precision diagnostics gain prominence, the demand for targeted sequencing services is likely to increase, driving its dominance in the market.
RNA Sequencing Services offer a powerful tool for studying gene expression patterns and identifying novel transcripts. As transcriptomics research garners increasing attention and the comprehension of genetic variations' functional ramifications deepens, there's a projected substantial expansion in the demand for RNA sequencing services.
De Novo Sequencing Services enable the assembly and analysis of genomes without the need for a reference sequence. These services find application in studies involving non-model organisms, population genomics, and evolutionary research. Despite their niche applications, the demand for de novo sequencing services is anticipated to grow steadily.
Exome Sequencing Services concentrate on sequencing solely the protein-coding sections of the genome, providing a cost-efficient option to whole genome sequencing. As exome sequencing facilitates the identification of disease-causing variants, it is expected to have a considerable market share.
Chip Sequencing Services utilize microarray or DNA chip technology for targeted sequencing, allowing for high-throughput analysis of DNA-protein interactions. The increasing adoption of chip sequencing in epigenetics and functional genomics research is likely to contribute to its market presence.
Whole Genome Sequencing Services involve sequencing the complete DNA content of an organism, providing comprehensive genomic information. While the demand for whole genome sequencing services is increasing, their higher costs and data analysis complexities might limit their dominance in the market.
Methyl Sequencing Services specialize in the analysis of DNA methylation patterns, playing a crucial role in epigenetics research and understanding disease mechanisms. The rising interest in epigenomics is expected to drive the growth of methyl sequencing services.
Other Services encompass various sequencing applications that do not fall under the aforementioned categories. These include metagenomics, infectious disease diagnostics, and forensic genomics. The demand for other services will depend on the specific application and research requirements.
Insights On Key Technology
Sequencing By Synthesis
Among the parts of the By Technology category, Sequencing By Synthesis is expected to dominate the Global Next-Generation Sequencing Services market. This technology utilizes a cyclic process that involves the synthesis of DNA fragments and the incorporation of fluorescently labeled nucleotides, enabling the determination of base sequences. With its widespread adoption and established performance, Sequencing By Synthesis has become the preferred choice for many researchers and institutions due to its accuracy, efficiency, and cost-effectiveness.
Ion Semiconductor Sequencing
Ion Semiconductor Sequencing, although not dominating, is an emerging part in the Global Next-Generation Sequencing Services market. This technology relies on the detection of hydrogen ions generated during DNA synthesis, allowing for the determination of base sequences. Ion Semiconductor Sequencing boasts various advantages, such as simplicity, rapidity, and scalability, rendering it suitable for diverse research and diagnostic purposes. Its affordability and alignment with semiconductor manufacturing procedures further enhance its potential for growth.
Single-molecule Real-time Sequencing
Single-molecule Real-time Sequencing holds promise as a part in the Global Next-Generation Sequencing Services market. This technology utilizes a single DNA molecule as a template, capturing real-time kinetics of nucleotide incorporation. Single-molecule Real-time Sequencing offers advantages such as long read lengths and high accuracy, making it suitable for applications requiring comprehensive genome analysis, transcriptomics, and epigenetics research. However, its higher cost and lower throughput compared to other technologies limit its widespread adoption.
Nanopore Sequencing
Nanopore Sequencing presents opportunities in the Global Next-Generation Sequencing Services market. This technology enables the identification of DNA bases by measuring changes in ionic currents as DNA molecules pass through nanopore channels. Nanopore Sequencing offers advantages such as real-time analysis, portability, and potential for single-molecule DNA sequencing. While it still faces challenges related to accuracy and cost-effectiveness, ongoing advancements and improvements continue to drive its development.
DNA Nanoball Sequencing
DNA Nanoball Sequencing, while not dominating, has potential in the Global Next-Generation Sequencing Services market. This technology involves the rolling circle amplification of short DNA fragments attached to solid surfaces, generating DNA nanoballs for sequencing. DNA Nanoball Sequencing offers advantages such as high throughput and low cost per sample, making it applicable in population-scale studies and other high-volume applications. However, its limitations in read length and consensus accuracy may restrict its use in certain research fields.
Insights On Key Application
Research Applications
The research applications part is expected to dominate the global next-generation sequencing services market. This is primarily due to the increasing adoption of next-generation sequencing technology in various research areas such as genomics, transcriptomics, epigenomics, and metagenomics. Researchers are employing these services to investigate genetic variations, comprehend disease mechanisms, and devise personalized therapeutics. Moreover, the availability of vast genomic data and advancements in sequencing technologies are further driving the growth of this part.
Clinical Applications
The clinical applications part holds significant potential in the global next-generation sequencing services market. Next-generation sequencing services are used in clinical settings for various purposes, including cancer diagnosis and treatment selection, genetic disorder screening, prenatal screening, infectious disease testing, and pharmacogenomics. The integration of genomic information into clinical practice for precision medicine initiatives is a key driver for the growth of this part. With advancements in technology, the application of next-generation sequencing services in clinical settings is expected to expand, contributing to market growth.
Insights On Key End User
Hospitals & Diagnostic Laboratories
The Hospitals & Diagnostic Laboratories part is expected to dominate the Global Next-Generation Sequencing Services market. This is primarily due to the increasing use of next-generation sequencing (NGS) services in hospital settings and diagnostic laboratories for various applications, including the diagnosis and treatment of genetic disorders, cancer profiling, and infectious disease testing. The adoption of NGS technology in these settings is driven by its ability to provide faster and accurate results, thereby enabling personalized medicine and improving patient outcomes.
Pharmaceutical & Biotechnology Companies
Pharmaceutical & Biotechnology Companies are another significant end user in the Global Next-Generation Sequencing Services market. These companies utilize NGS services for drug discovery and development, pharmacogenomics, biomarker identification, and clinical trials. The advancement in genomic research and the increasing focus on precision medicine by pharmaceutical and biotechnology companies are driving the demand for NGS services in this.
Academic Institutes & Research Centers
Academic Institutes & Research Centers also play a crucial role in the Global Next-Generation Sequencing Services market. These institutions utilize NGS technology for various research applications, such as understanding genetic variations, studying disease mechanisms, and conducting population-based studies. The increasing collaborations between academic institutes, research centers, and healthcare organizations further contribute to the demand for NGS services in this.
Other End Users
Although not dominating, other end users, such as government institutions, contract research organizations (CROs), and forensic laboratories, also contribute to the Global Next-Generation Sequencing Services market. These end users utilize NGS services for diverse purposes, including genomics research, forensic analysis, and tracking disease outbreaks. While their individual market share may be lower compared to the dominant s, the collective demand from these end users contributes to the overall growth of the NGS services market.
Insights on Regional Analysis:
North America
North America is poised to spearhead the global Next-Generation Sequencing Services market, driven by the region's robust focus on genomics research advancements, substantial investments in healthcare infrastructure, and the presence of key industry stakeholders. Furthermore, favorable government initiatives and collaborations between academia and industry are driving the market growth in this region. North America's dominance in the Next-Generation Sequencing Services market is further bolstered by the rising demand for personalized medicine and precision oncology initiatives.
Latin America
Latin America is witnessing steady growth in the Next-Generation Sequencing Services market. The region has been focusing on improving healthcare access, technological advancements, and research collaborations. Moreover, the escalating prevalence of chronic illnesses and the uptake of advanced genetic testing techniques drive the demand for Next-Generation Sequencing Services in Latin America.. However, compared to North America, Latin America still faces challenges related to infrastructure and limited funding, which affect the market's overall growth potential.
Asia Pacific
The Asia Pacific region is experiencing rapid expansion in the Next-Generation Sequencing Services market. This growth is propelled by factors including escalating healthcare spending, ened awareness regarding genetic disorders, and the presence of a substantial patient demographic. Additionally, countries like China, India, and Japan are actively investing in biotechnology and genomics research, contributing to the market's expansion. Nevertheless, hurdles such as the absence of standardization and regulatory barriers must be tackled to fully unleash the growth potential of the Next-Generation Sequencing Services market in the Asia Pacific region.
Europe
Europe stands as a significant market for Next-Generation Sequencing Services. The region has a well-established healthcare infrastructure, favorable reimbursement policies, and a strong base of pharmaceutical and biotechnology companies. The increasing incidence of genetic disorders, coupled with an aging population, is fueling the demand for Next-Generation Sequencing Services in Europe. However, regulatory intricacies and concerns regarding data privacy present obstacles to market expansion in the region.
Middle East & Africa
The Next-Generation Sequencing Services market in the Middle East & Africa region is relatively smaller compared to other regions. However, increasing investments in healthcare infrastructure, rising adoption of advanced technologies, and growing awareness about genetic testing and personalized medicine are propelling market growth. The region's high prevalence of rare genetic disorders and genetic variations unique to specific populations also create opportunities for the expansion of Next-Generation Sequencing Services. Despite these promising factors, limited access to advanced healthcare facilities and inadequate funding hinder the market's growth potential in the Middle East & Africa.
Company Profiles:
Prominent contributors in the international Next-Generation Sequencing Services industry encompass Illumina Inc., Thermo Fisher Scientific Inc., and Pacific Biosciences of California Inc. These entities stand at the forefront of delivering cutting-edge sequencing capabilities and solutions to meet the escalating need for genomic sequencing and analysis across global research, pharmaceutical, and clinical landscapes.
Prominent contributors to the Next-Generation Sequencing Services Market include Illumina, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., PerkinElmer, Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies, Inc., Eurofins Scientific SE, Pacific Biosciences of California, Inc., Oxford Nanopore Technologies Ltd., and Genotypic Technology Pvt Ltd. These industry leaders actively offer advanced sequencing services to sectors like pharmaceuticals, biotechnology, clinical research, and academia. Leveraging sophisticated sequencing technologies and specialized knowledge, these companies play a vital role in propelling innovation and progress within the genomics research and diagnostics domain.
COVID-19 Impact and Market Status:
The Covid-19 outbreak has led to a surge in demand for sequencing services within the global Next-Generation Sequencing Services market. This ened demand is driven by escalated research endeavors focused on comprehending the virus and its diverse strains.
The COVID-19 pandemic has had a notable impact on the Next-Generation Sequencing (NGS) Services sector, presenting a mix of advantages and disadvantages. The crisis has ened the necessity for NGS testing, crucial for comprehending the genomic structure of the virus, aiding in mutation tracking and treatment development. Nonetheless, supply chain disturbances, decreased research funding, and a slowdown in regular diagnostic procedures have adversely affected the market. Additionally, temporary closure of research facilities and limited healthcare access have further impeded the growth of the NGS services domain. In essence, the influence of the pandemic on the NGS services market has brought forth a blend of opportunities and obstacles.
Latest Trends and Innovation:
- Illumina acquires Pacific Biosciences on November 1, 2018.
- Thermo Fisher Scientific completes acquisition of Ion Torrent Systems, Inc. on October 11, 2010.
- BGI and GE Healthcare establish partnership for comprehensive genomics and personalized medicine on September 19, 2013.
- Roche acquires Genia Technologies, Inc. on June 19, 2014.
- Oxford Nanopore Technologies completes a £100 Million ($140 million) investment round on May 20, 2015.
- Qiagen launches new GeneReader NGS System on October 18, 2016.
- PerkinElmer acquires Eurofins NTD on January 5, 2021.
- Pacific Biosciences launches new Sequel II System on September 30, 2019.
- Illumina introduces new NextSeq 1000 and NextSeq 2000 Systems on October 20, 2020.
- Thermo Fisher Scientific launches new Ion Torrent Genexus System on April 10, 2019.
Significant Growth Factors:
The expansion of the Next-Generation Sequencing Services Market is driven by the growing embrace of precision medicine, progress in genomic studies, and the increasing need for tailored healthcare services.
The market for Next-Generation Sequencing (NGS) Services is witnessing notable growth driven by several key factors. Primarily, the rise in chronic diseases like cancer and genetic disorders has spurred demand for advanced genomic profiling, diagnosis, and personalized medicine made possible through NGS technology. Secondly, the decreasing costs associated with sequencing services have widened access to a broader consumer base, encompassing academic institutions, pharmaceutical firms, and research facilities. Moreover, the increasing range of applications for NGS in sectors such as agriculture, forensics, and reproductive health is expanding the market further. Advancements in NGS platforms, offering higher throughput, quicker turnaround times, and improved accuracy, have bolstered genomic analysis efficiency and reliability, fostering greater adoption of NGS services. Additionally, ened investments in genomics research and development and government initiatives supporting precision medicine have also played a role in market growth. Collaborations between sequencing service providers and healthcare entities, along with a surge in partnerships and acquisitions, are additional drivers propelling the growth of NGS services. Continuous advancements and innovation in NGS technology are expected to underpin sustained expansion in the market in the future.
Restraining Factors:
Constraints for the market arise from the restricted availability and expensive nature of advanced sequencing technology.
The Next-Generation Sequencing (NGS) Services Market has experienced substantial development recently, driven by the integration of NGS technologies in diverse research fields like genomics, oncology, and infectious diseases. Nevertheless, certain factors may act as obstacles to the market's growth. Primarily, the high costs related to NGS services are a significant hindrance, restricting accessibility for smaller laboratories and research institutions. Moreover, the intricate nature and technical complexities involved in NGS data analysis and interpretation require skilled professionals and expertise, presenting a challenge. The absence of standardized NGS protocols and workflows across different platforms and service providers can lead to inconsistencies and reliability issues, thereby impeding the widespread adoption of NGS services.
Additionally, concerns around data privacy and security, particularly concerning genomic data, have raised ethical and legal issues that could deter the use of NGS services. The availability of alternative technologies like microarrays and Sanger sequencing may present more cost-effective options for specific applications, thereby creating competition for NGS services. Notwithstanding these challenges, the Next-Generation Sequencing Services Market exhibits significant growth potential as ongoing research and development endeavors strive to tackle these limitations, enhance cost-efficiency, refine data analysis algorithms, and standardize protocols.
The ongoing advancements in NGS technologies, alongside the growing demand for personalized medicine and precision diagnostics, present a promising outlook for the future of the NGS services market.
Key Segments of the Next-Generation Sequencing Services Market
Type Overview
- Targeted Sequencing Services
- RNA Sequencing Services
- De Novo Sequencing Services
- Exome Sequencing Services
- Chip Sequencing Services
- Whole Genome Sequencing Services
- Methyl Sequencing Services
- Other Services
Technology Overview
- Sequencing By Synthesis
- Ion Semiconductor Sequencing
- Single-molecule Real-time Sequencing
- Nanopore Sequencing
- DNA Nanoball Sequencing
Application Overview
- Research Applications
- Clinical Applications
End User Overview
- Hospitals & Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Academic Institutes & Research Centers
- Other End Users
Regional Overview
North America
- US
- Canada
- Mexico
Europe
- Germany
- France
- U.K
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
Middle East and Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Frequently Asked Questions (FAQ) :
The top companies that hold the market share in next-generation sequencing services market are Illumina, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., PerkinElmer, Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies, Inc., Eurofins Scientific SE, Pacific Biosciences of California, Inc., Oxford Nanopore Technologies Ltd., and Genotypic Technology Pvt Ltd.
The global next-generation sequencing services market is segmented on the By Type, By Technology ,By Application,By End User,By Region.
To get latest version of next-generation sequencing services market report can be obtained on demand from the website.